Product Name: AGPAT9 Antibody
Species Reactivity: Human, Mouse
Tested Applications: WB
Applications: For WB starting dilution is: 1:1000
User Note: Optimal dilutions for each application to be determined by the researcher.
Predicted Molecular Weight: 49 kDa
Immunogen: This AGPAT9 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 194-222 amino acids from the Central region of human AGPAT9.
Host Species: Rabbit
Purification: This antibody is purified through a protein A column, followed by peptide affinity purification.
Physical State: Liquid
CAS NO.: 1782235-14-6
Product: CHIR-99021 (trihydrochloride)
Buffer: Supplied in PBS with 0.09% (W/V) sodium azide.
Concentration: 0.5 mg/ml
Storage Conditions: Store at 4˚C for three months and -20˚C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.
Clonality: Polyclonal
Conjugate: Unconjugated
Alternate Names: Glycerol-3-phosphate acyltransferase 3, GPAT-3, 1-acyl-sn-glycerol-3-phosphate O-acyltransferase 10, AGPAT 10, 1-acyl-sn-glycerol-3-phosphate O-acyltransferase 9, 1-AGP acyltransferase 9, 1-AGPAT 9, Acyl-CoA:glycerol-3-phosphate acyltransferase 3, hGPAT3, Lung cancer metastasis-associated protein 1, Lysophosphatidic acid acyltransferase theta, LPAAT-theta, MAG-1, AGPAT9, GPAT3, MAG1
Accession NO.: Q53EU6
Protein Ino: 150403919
Official Symbol: AGPAT9
Geneid: 84803
Background: Glycerol-3-phosphate (G3P) acyltransferases (GPAT; EC2.3.1.15), such as GPAM (MIM 602395) and GPAT3, catalyze theinitial step of de novo triacylglycerol (TAG) synthesis byconverting glycerol-3-phosphate (G3P) to lysophosphatidic acid(LPA) (Cao et al., 2006 [PubMed 17170135]).
PubMed ID:http://aac.asm.org/content/52/6/2242.abstract
